Company: THC
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0000070318-25-000039
Chunk: 96

Company: TENET HEALTHCARE CORP
Filing Date: 2025-07-30
Form: 10-Q
Item: Part I, Item 2
Chunk 96
---
 state interest limitations and the utilization of interest expense carryforwards. The decrease in our valuation allowance during the six months ended June 30, 2024 was primarily related to the utilization of interest expense carryforwards primarily due to gains from sales of facilities and state interest limitations. 

Net Income Available to Noncontrolling Interests

The table below presents net income available to noncontrolling interests by segment for the periods indicated:

Three Months EndedJune 30,Six Months EndedJune 30,2025202420252024Hospital Operations$39 $44 $78 $74 Ambulatory Care195 174 372 327 Total net income available to noncontrolling interests$234 $218 $450 $401 

40

LIQUIDITY AND CAPITAL RESOURCES

CASH REQUIREMENTS

There have been no material changes to our obligations to make future cash payments under scheduled contractual obligations, such as debt and lease agreements, and under contingent commitments, such as standby letters of credit and minimum revenue guarantees, as disclosed in our Annual Report, except for the matters set forth below and the additional lease obligations disclosed in Note 1 to our accompanying Condensed Consolidated Financial Statements.

Long-Term Debt

Interest payments, net of capitalized interest, were $399 million and $459 million in the six months ended June 30, 2025 and 2024, respectively.

Other Cash Requirements

Our capital expenditures primarily relate to the expansion and renovation of existing facilities, hospital expansion focused on higher acuity services, equipment and information systems additions and replacements, introduction of new medical technologies, design and construction of new facilities, and various other capital improvements. Capital expenditures were $366 million and $385 million in the six months ended June 30, 2025 and 2024, respectively. We anticipate that our capital expenditures for the year ending December 31, 2025 will total approximately $725 million to $825 million, including $127 million that was accrued as a liability at December 31, 2024.

We made income tax payments, net of tax refunds, of $242 million during the six months ended June 30, 2025 and $240 million during the six months ended June 30, 2024. The current portion of our income tax payable was $25 million at June 30, 2025 and $18 million at December 31, 2024.

SOURCES AND USES OF CASH